Diego, thanks for posting, it was great to read some of the roadshow notes. It appears all is coming together nicely. I'm still more comfortable with our partnerships rather than the internal product, however if Bodyguard was launched in conjunction with someone such as Nike, then I'd be over the moon!
I see this as a strong buy under 10c based solely on the MC of other ASX listed biotechs and what they have to offer. It's a shame the downrampers have scared a few people away. You need patience to be invested in this end of the industry. It seems many expect to be an overnight millionaire. Maybe y'all should trade forex for your short term fix
OBJ Price at posting:
8.4¢ Sentiment: Buy Disclosure: Held